SCHEMBL17694342

SCHEMBL17694342

CCCCCc1ccc(-c2ccc(-c3ccc(-c4ccc(-c5ccc(CCCCC)cc5F)s4)c4nsnc34)c(F)c2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RARB P10826 10/20 0.44
▸ RARA P10276 2/20 0.44
▸ RARG P13631 1/20 0.44
▸ KDM4E B2RXH2 2/20 0.37
▸ RAB9A P51151 2/20 0.37
▸ HSD17B10 Q99714 2/20 0.34
▸ TSHR P16473 1/20 0.34
▸ MAPT P10636 3/20 0.33
▸ MEN1 O00255 2/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ KMT2A Q03164 2/20 0.33
▸ MTOR P42345 1/20 0.33
▸ HTR2A P28223 1/20 0.33
▸ USP2 O75604 1/20 0.32
▸ GAA P10253 1/20 0.32
▸ HPGD P15428 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ HRH3 Q9Y5N1 1/20 0.32
▸ HSD11B1 P28845 1/20 0.32
▸ GPR3 P46089 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20647290 0.97 RARB (0.40) RARBRARARARGKDM4ERAB9A
SCHEMBL17694315 0.91 RARB (0.40) RARBRARARARGKDM4ERAB9A
SCHEMBL17694324 0.90 RARB (0.39) RARBRARARARGKDM4ERAB9A
SCHEMBL17694316 0.90 RARB (0.42) RARBRARARARGKDM4ERAB9A
SCHEMBL17694346 0.90 RARB (0.39) RARBRARARARGKDM4ERAB9A
SCHEMBL16265324 0.90 RARB (0.52) RARBRARARARGKDM4ERAB9A
SCHEMBL17694321 0.89 RARB (0.39) RARBRARARARGKDM4ERAB9A
SCHEMBL17694322 0.88 RARB (0.38) RARBRARARARGKDM4ERAB9A
SCHEMBL22268268 0.87 S1PR1 (0.42) RARBRARARARGRAB9AMAPT
SCHEMBL17694335 0.86 RARB (0.48) RARBRARARARGKDM4ERAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170029702-A1 LIQUID CRYSTAL MATERIAL MERCK PATENT GMBH (DE) 2017-02-02 — — US disclosed
US-20160108317-A1 DEVICE FOR CONTROLLING THE PASSAGE OF ENERGY, CONTAINING A DICHROIC DYE COMPOUND MERCK PATENT GMBH (DE) 2016-04-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160108317-A1 DEVICE FOR CONTROLLING THE PASSAGE OF ENERGY, CONTAINING A DICHROIC DYE COMPOUND CRY1, SLC25A1, CRY2 RARB 172/4885RARA 175/4885RARG 198/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback